Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
抗感染儿科线的销售1.86B75.96%
集采和新零售线的销售346.08M14.10%
慢病线的销售179.94M7.33%
新药线的销售40.85M1.66%
其他业务的销售23.37M0.95%
Product
No Data
Region
Currency:CNY
2023/H1
Stock NameRevenueRatio
The mainland of China3.21B100.00%